Alpha-aminoadipate Retinal Cell Regeneration Vision Restoration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for vision loss due to retinal cell damage primarily focus on controlling the cause of illness rather than reversing retinal neuron damage or replacing lost cells, with no effective therapies available to stimulate retina regeneration or restore vision.
Innovation Solution
Alpha-aminoadipate (α-AA) stimulates the proliferation and trans-differentiation of retinal cells into retinal progenitor cells, creating a conducive environment for photoreceptor differentiation, thereby enhancing photoreceptor activity and restoring vision, and is used in compositions for administering to injured or diseased eyes to mobilize endogenous stem cells for repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If retinal cell transplantation is used to replace lost cells, then vision restoration is achieved, but immune rejection and tumor formation risks increase
Solution Approach 1:
The patent utilizes endogenous retinal stem cells that are already present in the retina to regenerate lost photoreceptors. By activating these self-existing cells through alpha-aminoadipate treatment, the retina performs self-repair without requiring external transplanted cells, thereby eliminating immune rejection and tumor formation risks while achieving vision restoration
2Reliability
If current therapies targeting the cause of illness are used, then disease progression is controlled, but lost retinal cells are not replaced
Solution Approach 1:
The patent applies alpha-aminoadipate treatment to preemptively activate retinal stem cells and create a permissive environment for photoreceptor differentiation before complete cell loss occurs. This preliminary activation of regenerative mechanisms addresses both disease control and cell replacement by stimulating endogenous repair processes early in the disease progression
3Object-affected harmful factors
If retinal stem cell activation is stimulated to regenerate cells endogenously, then immune rejection risk is reduced, but treatment complexity increases
Solution Approach 1:
The patent replaces the complex mechanical and surgical procedure of cell transplantation with a simple chemical treatment approach. By using alpha-aminoadipate to chemically activate endogenous stem cells, the treatment achieves cell regeneration without surgical intervention, thereby reducing both immune rejection risk and treatment complexity
Data Source
AI summary
The invention provides compositions and methods for preserving, restoring, or enhancing vision of a subject by administering compositions to an injured or diseased eye.